Stay updated on Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.

Latest updates to the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the funding lapse notice and prior Revision: v3.4.1.SummaryDifference0.2%

- Check21 days agoChange DetectedThe page now includes a site-wide notice about a lapse in government funding and potential delays, and the revision note shows version 3.4.1 (previously 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedA glossary toggle is now shown; the QC criteria label reads 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' capitalization has been adjusted, and the revision label changed to v3.4.0 (replacing v3.3.4).SummaryDifference0.1%

- Check35 days agoChange DetectedRevision history shows an addition of Revision: v3.3.4 and a deletion of Revision: v3.3.3. This is a minor metadata update.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a new Locations section and expanded the list of study sites across multiple regions (e.g., Arizona, California, Nova Scotia, Emilia-Romagna, São Paulo, Barcelona, etc.). The locations are now organized under regional headings, and this update is labeled Revision: v3.3.3.SummaryDifference2%

- Check85 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2; there are no visible changes to study content or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Prodromal Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Prodromal Alzheimer's: Clinical Trial page.